Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Safety and Efficacy of Gabapentin for Postoperative Analgesia After Surface Ablation, Versus Diclofenac Potassium as a Gold Standard

NCT06752486 is registered in ClinicalTrials.gov with Research Institute of Ophthalmology, Egypt as lead sponsor.

NCT NCT06752486
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06752486 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Safety and Efficacy of Gabapentin for Postoperative Analgesia After Surface Ablation, Versus Diclofenac Potassium as a Gold Standard
Lead sponsor
Research Institute of Ophthalmology, Egypt
Phase
Phase 1
Overall status
Recruiting
Start date
December 1, 2024
Completion date
June 30, 2025
Enrollment
64 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pain after photorefractive keratectomy, vas will be used to assess pain postoperative